🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objectives of the study were: 1. To assess the safety and tolerability...
Status
Completed
Location
Allergy, Asthma and Immunology Associates
Start Date
2009-08-31
Trial ID
NCT00914966
Treatments Being Tested
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
The aim of the present study to investigate whether * Opening of KATP chan...
Status
Unknown
Location
Danish headache center
Start Date
2022-09-01
Trial ID
NCT05565001
Treatments Being Tested
The study aims to assess the potential benefit and evaluate the safety and ...
Status
Terminated
Location
Research Site
Start Date
2020-08-28
Trial ID
NCT04526912
It is important to choose an appropriate oxygenation technique during intra...
Status
Unknown
Location
Peking University of Stomatology
Start Date
2023-06-01
Trial ID
NCT05762692
Treatments Being Tested
The purpose of this study is to assess if a zoledronic acid injection can a...
Status
Terminated
Location
University of Calgary
Start Date
2023-05-16
Trial ID
NCT05204836
Treatments Being Tested
The study proposes to evaluate the safety, tolerability, and efficacy of PD...
Status
Terminated
Location
Mount Sinai School Of Medicine/Mount Sinai Medical Center
Start Date
2013-03-15
Trial ID
NCT01732211
Treatments Being Tested
Acute kidney injury(AKI) is a common, severe emergency case in clinics,espe...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2021-12-31
Trial ID
NCT04194671
Treatments Being Tested
The purpose of this study is to examine the pre, post, and follow up effect...
Status
Completed
Location
Reno Orthopedic Center
Start Date
2020-11-30
Trial ID
NCT05058209
Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-01
Trial ID
NCT04767009
Treatments Being Tested